Physician profile
Lawrence Grobman
NPI 1245230994
$1,148.04
in general payments reported to CMS, 2019-2025
12 companies · $500 in 2025
The $500 reported for 2025 was more than what a typical Otology & Neurotology provider received nationally (typical 2025 total: $411).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.27 · 2020: $134 · 2021: $26.75 · 2022: $218 · 2023: $17.29 · 2024: $153 · 2025: $500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $671.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $670.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $512.37 | 2022-2025 | Propel, Sinuva, Nuvent |
| Cochlear Americas | $220.87 | 2020-2022 | |
| Med-El Corporation | $169.36 | 2019-2023 | Mi1250 Synchrony 2 Flexsoft |
| Glaxosmithkline, LLC. | $56.88 | 2024-2025 | Nucala |
| Hikma Pharmaceuticals USA | $36.28 | 2024 | Ryaltris |
| Integra Lifesciences Corporation | $33.17 | 2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Ambu INC. | $26.75 | 2021 | |
| Kerecis Limited | $23.49 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Aerin Medical INC. | $22.51 | 2025 | |
| Novartis Pharmaceuticals Corporation | $19.49 | 2019 | |
| Advanced Bionics, LLC | $13.88 | 2019 | |
| Medtronic USA, INC. | $12.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Grobman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.